Main Session
Sep 29
PQA 07 - Head and Neck Cancer, Lung Cancer/Thoracic Malignancies, and Nursing and Supportive Care

3553 - Survival Outcomes in Inoperable Stage III NSCLC: Comparing Immunotherapy (+/- Chemotherapy) followed by Radiotherapy vs. Standard of Care Chemoradiation Followed by Adjuvant Durvalumab

03:45pm - 05:00pm ET
Poster Hall - Exhibit Hall A

Presenter(s)

Mary Mahoney, MD Headshot
Mary Mahoney, MD - Fox Chase Cancer Center, Philadelphia, PA